Clinical records

Studies/Post-marketing surveillance studies

Studies/Post-marketing surveillance studies

Medaxis' debritom⁺ has already been tested and evaluated in some applications in the past. The journal of aesthetic and surgical dermatology, Kammerlander Consulting, as well as Prof. Dr. Luc Téot of Clinical, Nursing and Patient Care monitored the first generation debritom device. The results can be summarized as follows:

  • debritom⁺ significantly reduces the time needed for cleaning wounds.
  • The instrument can be used by both physicians and other health care professionals.
  • The applications with debritom⁺ is relatively painless.

Call for study participation

If you are a physician or wound care professional and are interested in conducting a study, please do not hesitate to contact us.